MET and non-small cell lung carcinoma: Activation of the HGF/c‐MET signaling pathway has also been found to be associated with a poor prognosis in various solid tumors including NSCLC (Guo et al., 2014; Zhang et al., 2015), indicating a predictive value for this disease.